FDA lifts hold on GeneTx, Ultragenyx study of Angelman therapy
While the clinical hold lifting is encouraging news for the companies' partnership, questions still loom about safety in the genetic medicine field. Earlier this mont...
From Depression to Deep-Learning: Leveraging iPSC and AI Platforms for Evidence-Based Depression Treatment
Continue readingAdvertisement
Advertisement
Advertisement
Advertisement
Advertisement